--- title: 'Manufacturing Daily Summary: What Happened on October 20, 2026' headline: Bayer plans $2.2 billion Ohio manufacturing campus description: GSK’s $800 million Pennsylvania hub is expected to create more than 300 jobs over five years. url: https://thebench.bio/news/manufacturing/2026-10-20 topic: manufacturing date: '2026-10-20' covers: - '2026-10-20' date_published: '2026-10-21T00:02:41Z' date_modified: '2026-10-21T00:02:41Z' tags: - Industry - Manufacturing sources: 2 publisher: TheBench.Bio --- # Manufacturing Daily Summary: What Happened on October 20, 2026 **Bayer plans $2.2 billion Ohio manufacturing campus** GSK’s $800 million Pennsylvania hub is expected to create more than 300 jobs over five years. ## Today in brief Bayer plans a $2.2 billion drug-manufacturing campus in New Albany, Ohio, with its first production lines targeted to start operating in 2031. [1] The project is expected to support about 1,500 construction jobs and create about 600 permanent jobs. [1] GSK plans an $800 million research and manufacturing hub in Pennsylvania, with more than 300 jobs expected over five years. [2] ## Bayer targets 2031 for first Ohio production lines Bayer plans to invest $2.2 billion in a New Albany, Ohio, campus initially focused on cancer, cardiovascular and kidney therapies. [1] The modular site is designed to make drug substance, the active ingredient, and finished medicines. [1] The first drug-substance production lines are targeted for 2031, followed by a product-manufacturing module in 2034. [1] Bayer expects the project to create about 600 permanent jobs, while construction is expected to support about 1,500 jobs. [1] Bayer said the investment is part of the $7 billion it allocated to U.S. research and development and manufacturing over the past five years. [1] The company said the campus will expand its global supply network and improve its ability to serve markets reliably. [1] ## The day in numbers - **$2.2 billion**: Bayer’s planned investment in the New Albany, Ohio, manufacturing campus. [1] - **2031**: Target year for the first drug-substance production lines at Bayer’s Ohio campus. [1] - **More than 300**: Jobs GSK expects its Pennsylvania expansion to create over five years. [2] ## Also published - [Building a Pragmatic E&L Framework for New Modalities](), Fierce Pharma - [PAXAFE’s Mark Talens: Supply Chain Teams Must Shift From Firefighters to Orchestrators](), Pharmaceutical Commerce - [AGCO and Agility Robotics Advance Smart Manufacturing with Humanoid Robot Pilot in Hesston, KS, Facility](), CropLife - [Where Cold Chain Expertise Gaps Put Advanced Therapies at Risk](), Pharmaceutical Commerce - [Medtech execs share secrets to building resilient supply chains](), MedTech Dive ## Sources 1. [Bayer plans to build $2.2B Ohio drug manufacturing site](), Pharmaceutical Processing World, 2026-10-20 2. [GSK invests another $800M in Pennsylvania site expansions](), Pharmaceutical Processing World, 2026-10-20 --- TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing. [1]: [2]: